Close Menu

NEW YORK — South Korean diagnostics firm Bioneer said on Wednesday that it has received CE-IVD marking for two combination tests for SARS-CoV-2 and influenza.

The AccuPower RV1 Real-Time RT-PCR Kit and the AccuPower RV1 Multiplex Kit are both designed to detect the E, RdRp, and N genes of SARS-CoV-2, as well as influenza A and B, in a single nasopharyngeal or oropharyngeal sample.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.